Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study
STEM faculty who believe ability is fixed have larger racial achievement gaps and inspire less student motivation in their classes
Iterative Usage of Fixed and Random Effect Models for Powerful and Efficient Genome-Wide Association Studies
